Peptide Therapy — 50+ Physician-Prescribed Peptides | Luxbae West Hollywood

Luxbae · Physician-Prescribed Peptide Directory

Peptides

a complete clinical reference, prescribed at Luxbae

A comprehensive directory of 50+ peptides — including GLP-1 receptor agonists for weight management, growth hormone secretagogues, recovery and tissue-repair compounds, and the copper-binding tripeptide behind our signature Glow Fusion protocol. Curated and supervised by Dr. Ernst von Schwarz, MD, PhD.

50+
Peptide Compounds
7
Clinical Categories
MD
Triple Board-Certified
Free
Consultation
The Science · Why Peptides

Signaling molecules, not stimulants

Peptides are short chains of amino acids — typically two to fifty residues — that act as the body’s native messenger system. They bind to specific cell-surface receptors and instruct downstream cascades: tell the pituitary to release growth hormone, tell dermal fibroblasts to deposit collagen, tell appetite-regulating neurons in the hypothalamus to stop firing.

That receptor-specific signaling is what makes prescribed peptides different from supplements. A supplement adds raw material to your bloodstream and hopes for the best. A correctly dosed peptide modulates a single biological pathway with predictable, measurable effects.

At Luxbae, every protocol begins with a complimentary medical consultation, baseline lab work where indicated, and ongoing follow-ups to refine dosing as your physiology responds. We do not sell preset packages. We do not skip labs. Every compound on this directory is prescribed only after a physician has reviewed your history.

Peptide therapy at Luxbae Med Spa
Standards of Care

Four non-negotiables

01

MD-Prescribed

Every protocol is written by Dr. Ernst von Schwarz personally, not by a sales rep or template engine. Your prescription reflects your labs, history, and goals.

02

Pharmacy-Grade Compounding

Every peptide we dispense comes from FDA-registered 503A or 503B compounding pharmacies with certificates of analysis on purity, potency, and sterility.

03

Lab-Anchored

For hormone-axis and metabolic peptides we draw baseline labs first and re-lab at 6–8 weeks. Dosing decisions are made against your numbers, not vibes.

04

Continuity of Care

Direct access to your medical team between appointments — for questions, side effects, dosing tweaks, or sequencing around in-spa treatments like Morpheus8 or CO2 resurfacing.

01 · Aesthetic & Skin

Skin Quality, Glow & Cellular Radiance

Copper-binding tripeptides, pineal tetrapeptides, and melanocortin agonists studied for collagen synthesis, dermal fibroblast activation, skin pigmentation, and post-procedure repair. The category most relevant to Luxbae’s aesthetic clientele and our signature Glow Fusion protocol.

GHK-Cu

Copper Peptide

Originally isolated from human plasma in 1973. The copper-bound complex modulates over 4,000 genes including those for skin remodeling and antioxidant defense — Luxbae's most-prescribed aesthetic peptide.

GHK-Cu

Epithalon

Pineal Tetrapeptide

Discovered in the 1980s at the St. Petersburg Institute of Bioregulation. Four amino acids hypothesized to upregulate telomerase activity and reset circadian rhythm — an investigational longevity compound.

Epithalon

GHK / EpithalonBlend

Aesthetic Longevity Stack

Layered protocol pairing the dermal-regeneration of GHK-Cu with the telomere-maintenance of Epithalon. Frequently prescribed when patients want surface aesthetics and cellular-age markers addressed in parallel.

GHK / Epithalon Blend

GHK / Epi / MOTS-cBlend

Whole-Body Glow

Three-peptide stack combining skin remodeling (GHK-Cu), telomere signaling (Epithalon), and mitochondrial-derived energy modulation (MOTS-c). Our most comprehensive aesthetic-longevity prescription.

GHK / Epi / MOTS-c Blend

Melanotan-2

Melanocortin Agonist

Synthetic analogue of alpha-melanocyte-stimulating hormone. Binds MC1R for pigment production and MC4R for centrally-mediated arousal. Prescribed selectively; not appropriate for every patient profile.

Melanotan-2
02 · Longevity & Growth Hormone

The Growth Hormone Axis & Senescence Frontier

GHRH analogues, ghrelin mimetics, and downstream IGF-1 signalers studied for body composition, sleep depth, recovery, and the biological markers of aging. Designed to restore pulsatile growth hormone release rather than override it.

CJC-1295

GHRH Analogue

Modified GHRH with extended half-life via drug-affinity-complex technology. Maintains tonically elevated GH secretion across multi-day windows. The backbone of our growth-hormone protocols.

CJC-1295

CJC-1295 / IpamorelinBlend

Signature GH Stack

The two-peptide combination most physicians reach for first. CJC sustains baseline GH; Ipamorelin produces clean pulsatile spikes through ghrelin-receptor activation — mirroring native pituitary patterns.

CJC-1295 / Ipamorelin Blend

Ipamorelin

Ghrelin Receptor Agonist

A pentapeptide ghrelin mimetic with selective GH-secretagogue activity. Unlike older compounds (GHRP-2, GHRP-6, hexarelin), produces minimal cortisol or prolactin elevation.

Ipamorelin

IPA / CJC / IGFBlend

Triple-Action GH

Triple-action protocol engaging the entire somatotropic axis: ghrelin-receptor pulses (IPA), sustained GHRH signaling (CJC), and direct IGF-1 receptor agonism. For advanced anti-aging cases.

IPA / CJC / IGF Blend

IPA / SermorelinBlend

Gentle Restoration

Short-half-life GHRH (Sermorelin) paired with selective ghrelin mimetic (Ipamorelin). Mirrors physiologic GH pulses without the prolonged elevation of longer GHRH analogues.

IPA / Sermorelin Blend

Sermorelin

GHRH Analogue

A 29-amino-acid GHRH fragment originally FDA-approved as Geref. Restores native pituitary pulse architecture and has one of the longest clinical safety records in the entire peptide category.

Sermorelin

Tesamorelin

GHRH Analogue

FDA-approved as Egrifta for HIV lipodystrophy. Selectively reduces visceral adipose tissue with documented efficacy in randomized trials (Falutz et al.). Used off-label for body recomposition under MD supervision.

Tesamorelin

Tesa / Ipa / MOTS-cBlend

Advanced Anti-Aging

Combines visceral-fat-targeted GHRH (Tesamorelin), pulsatile GH release (Ipamorelin), and mitochondrial-derived energy signaling (MOTS-c) — a triple-mechanism anti-aging protocol.

Tesa / Ipa / MOTS-c Blend

IGF-1 LR3

Insulin-Like Growth Factor

Long-acting recombinant IGF-1 analogue with extended half-life. The downstream anabolic mediator of GH signaling — drives muscle protein synthesis and satellite-cell activation.

IGF-1 LR3

IGF-LR3 / MOTS-cBlend

Performance Pair

Anabolic muscle signaling (IGF-1 LR3) combined with mitochondrial biogenesis (MOTS-c). Designed for the patient pursuing strength, recovery, and metabolic flexibility simultaneously.

IGF-LR3 / MOTS-c Blend

FOXO4-DRIComing Soon

Senolytic Peptide

An investigational FOXO4-binding peptide studied for selective clearance of senescent cells via p53/FOXO4 pathway disruption. Currently in early research at Luxbae — coming soon.

FOXO4-DRI

FollistatinComing Soon

Myostatin Inhibitor

Glycoprotein that neutralizes circulating myostatin, releasing the natural inhibition on muscle hypertrophy. Advanced and experimental; reserved for closely-monitored cases — coming soon.

Follistatin
03 · Recovery & Tissue Repair

Healing Acceleration & Post-Procedure Repair

BPC-157, Thymosin Beta-4, cathelicidin antimicrobials, and synergistic stacks studied for angiogenesis, tendon and ligament repair, GI lining integrity, and post-procedure healing. Especially relevant before and after Morpheus8, CO2 resurfacing, microneedling, and PRP.

BPC-157

Body Protection Compound

Originally isolated from human gastric juice (BPC = Body Protection Compound). Sikiric and colleagues at the University of Zagreb have published the most extensive preclinical body on tissue-repair effects.

BPC-157

TB-500

Thymosin Beta-4 Fragment

Synthetic fragment of Thymosin Beta-4. Sequesters actin monomers and facilitates cell migration — the molecular event underlying tissue regeneration in joint, dermal, cardiac, and neural models.

TB-500

BPC / TB-500 5mgBlend

Foundational Recovery

The benchmark 5mg recovery protocol pairing BPC-157's angiogenic and gastrointestinal repair effects with TB-500's systemic tissue regeneration. Our most-prescribed post-procedure recovery stack.

BPC / TB-500 5mg Blend

BPC / TB-500 15mgBlend

High-Dose Recovery

Higher-dose 15mg variant of the BPC/TB stack. Reserved for post-surgical recovery, chronic joint pathology, or athletes returning from significant tissue injury — used selectively under physician oversight.

BPC / TB-500 15mg Blend

TB / BPC / KPV / GHKQuad

Comprehensive Recovery

A four-peptide formulation engineered for clients with both healing and aesthetic concerns: tissue repair (BPC+TB), gut anti-inflammatory signaling (KPV), and dermal collagen stimulation (GHK-Cu).

TB / BPC / KPV / GHK Quad Blend

LL-37

Cathelicidin Antimicrobial

Human cathelicidin antimicrobial peptide. Studied for biofilm disruption, immune modulation, and chronic wound healing — particularly relevant in tick-borne illnesses and treatment-resistant infections.

LL-37

BPC-157 OralOral

GI-Targeted

Stabilized oral capsule formulation of BPC-157 with enteric protection. Preferred when targeting gastrointestinal lining specifically, or when patients prefer to avoid injection routes.

BPC-157 Oral
04 · Weight & Metabolic

Incretin Mimetics & Metabolic Optimization

From targeted lipolytic HGH fragments to dual incretin receptor agonists, these compounds address appetite signaling, insulin sensitivity, gastric emptying, and energy expenditure — the molecular machinery of durable weight reduction.

AOD-9604

HGH Fragment 176-191

The C-terminal fragment of human growth hormone (residues 176-191). Retains GH's lipolytic activity without engaging IGF-1 or glucose pathways — fat metabolism without systemic GH load.

AOD-9604

Semaglutide S5

GLP-1 Receptor Agonist

Entry-tier GLP-1 receptor agonist concentration. Allows the gentlest titration curve for patients beginning weight management — designed to acclimate the GI system to incretin signaling.

Semaglutide S5

Semaglutide S10

GLP-1 Receptor Agonist

Mid-dose semaglutide concentration, the most-prescribed tier for patients with established tolerance. Provides meaningful appetite regulation and weight reduction at a sustainable clinical cadence.

Semaglutide S10

Semaglutide S20

GLP-1 Receptor Agonist

Maintenance-grade semaglutide concentration. Equivalent steady-state delivery to brand-name Wegovy 2.4mg/week. Used for long-term metabolic maintenance with documented cardiovascular benefit per the SELECT trial.

Semaglutide S20

Tirzepatide

Dual GIP/GLP-1 Agonist

Novel dual incretin receptor agonist activating both GIP and GLP-1 pathways. SURMOUNT trials demonstrated up to 22.5% mean body-weight reduction at 72 weeks — superior to any single-agonist GLP-1.

Tirzepatide

CagrilintideComing Soon

Amylin Analogue

Long-acting amylin analogue under clinical development. Modulates appetite via the area postrema and slows gastric emptying. Synergistic potential alongside GLP-1 agonists — coming soon.

Cagrilintide

TesofensineComing Soon

Triple Reuptake Inhibitor

Investigational triple monoamine reuptake inhibitor (serotonin/norepinephrine/dopamine). Studied for combined appetite suppression and increased resting energy expenditure — a different mechanism from incretins.

Tesofensine
05 · Cognitive & Neurological

Nootropic Signaling & Sleep Architecture

Peptides studied for their ability to cross the blood-brain barrier and modulate BDNF, GABAergic signaling, synaptogenesis, and delta-wave sleep — supporting cognitive performance without the dependence profile of stimulant nootropics.

Dihexa

Synaptogenic Peptide

Hepatocyte growth factor (HGF) potentiator derived from angiotensin IV. In preclinical models drives synaptogenesis at concentrations seven orders of magnitude lower than BDNF itself.

Dihexa

Semax

ACTH Heptapeptide

Synthetic ACTH(4-10) analogue developed in Russia. Crosses the blood-brain barrier intranasally and upregulates BDNF/NGF expression. Used clinically in Russia for stroke and cognitive disorders since the 1990s.

Semax

Selank

Anxiolytic Neuropeptide

Heptapeptide derivative of the immunomodulator tuftsin. Modulates GABAergic and serotonergic signaling for anxiolytic effect without sedation — designed as a non-benzodiazepine anxiety compound.

Selank

DSIP

Delta Sleep-Inducing Peptide

Delta Sleep-Inducing Peptide, an endogenous nonapeptide. Studied for normalization of delta-wave architecture and modulation of the HPA stress axis — supports restorative sleep rather than sedation.

DSIP

DSIP / SelankBlend

Sleep + Anxiety

Sleep-architecture support (DSIP) combined with daytime anxiolytic signaling (Selank). The 24-hour stress-management protocol favored by patients in demanding professional environments.

DSIP / Selank Blend

Semax / Selank / DSIPBlend

Comprehensive Cognitive

Triple cognitive coverage: BDNF/NGF upregulation (Semax daytime), GABAergic anxiolysis (Selank daytime), and delta-wave sleep restoration (DSIP nighttime). Our most-comprehensive cognitive prescription.

Semax / Selank / DSIP Blend

5-Amino-1MQOral

NNMT Inhibitor

Small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Increases intracellular NAD+ pools and methyl donors in adipocytes. Oral capsule with metabolic and cognitive applications.

5-Amino-1MQ
06 · Sexual & Hormonal

Vitality & Hormonal Axis Support

Centrally and peripherally acting peptides studied for libido, arousal, GnRH and gonadotropin signaling, and the relational neurochemistry of oxytocin — for both men and women, only prescribed after a thorough medical evaluation.

PT-141 (Bremelanotide)

Melanocortin Agonist

Cyclic heptapeptide melanocortin agonist. FDA-approved as Vyleesi for premenopausal HSDD. Acts centrally on MC3R/MC4R rather than through vascular pathways — works regardless of underlying cause.

PT-141 (Bremelanotide)

Kisspeptin

Master Hypothalamic Signaler

Kiss1 gene product. Upstream of GnRH in the hypothalamic-pituitary-gonadal axis — effectively the master regulator that turns puberty on and reproductive cycling on/off.

Kisspeptin

Gonadorelin

GnRH Analogue

Synthetic decapeptide identical to native GnRH. Used during testosterone replacement therapy to maintain testicular size, intratesticular testosterone, and fertility-preserving function.

Gonadorelin

Oxytocin

Pair-Bond Neuropeptide

Hypothalamic nonapeptide synthesized in the paraventricular and supraoptic nuclei. Modulates pair-bonding, trust, cortisol response, and orgasm physiology. Prescribed sublingually or by injection.

Oxytocin
07 · Immune & Cellular Health

Immune Modulation & Cellular Energy

Thymic peptides, mitochondrial signalers, antimicrobials, and the essential coenzyme NAD+ — studied for T-cell regulation, innate immune balance, AMPK activation, and the cellular energy systems that decline measurably with age.

Thymosin Alpha-1

Thymic Immune Peptide

28-amino-acid thymic peptide first isolated by Goldstein. Modulates T-cell maturation and dendritic cell function. Approved internationally (Zadaxin) for chronic hepatitis and immune dysfunction conditions.

Thymosin Alpha-1

KPV

α-MSH Tripeptide

The C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH. Despite its small size, retains potent anti-inflammatory activity — investigated in inflammatory bowel disease, atopic dermatitis, and psoriasis models.

KPV

KPV / TA-1 / LL-37Blend

Triple Immune Support

Triple immune protocol: anti-inflammatory tripeptide (KPV), T-cell modulating thymic peptide (Thymosin Alpha-1), and antimicrobial cathelicidin (LL-37). Comprehensive immune-system support.

KPV / TA-1 / LL-37 Blend

MOTS-c

Mitochondrial Peptide

Mitochondrial-encoded peptide discovered in 2015 (Lee/Cohen labs). Translocates from mitochondria to nucleus to upregulate AMPK and metabolic-stress response genes — one of the most-studied mito-peptides.

MOTS-c

NAD+

Cellular Coenzyme

Nicotinamide Adenine Dinucleotide. The essential cofactor for sirtuin enzymes (longevity) and PARP enzymes (DNA repair). Tissue concentrations decline measurably with age — restored via IV or subQ delivery.

NAD+

KPV OralOral

GI-Targeted

Enterically-protected oral capsule of KPV. Survives gastric transit to deliver anti-inflammatory tripeptide signaling to the GI tract — used for IBD and gut-permeability indications.

KPV Oral

SLU-PP-332Coming Soon

Exercise Mimetic

Selective ERR (estrogen-related receptor) agonist developed by St. Louis University. Investigational exercise-mimetic — early data shows cardiovascular and metabolic benefits without physical exertion. Coming soon.

SLU-PP-332
Why Luxbae

Different by medical design

There is no shortage of online peptide vendors. There is, however, a meaningful difference between buying a research chemical and being prescribed a clinically supervised protocol. Here is what that difference looks like.

Physician at the Helm

Dr. Ernst von Schwarz is a triple board-certified clinical and academic cardiologist, clinical professor of medicine at UCLA, and a three-decade pioneer in stem cell and regenerative medicine. Every Luxbae protocol is written or reviewed under his direction.

Aesthetic Integration

Our peptides are sequenced around our in-spa procedures — Morpheus8, CO2 resurfacing, PRP, Biologique Recherche — so the molecular and the topical work in concert rather than against each other.

No Preset Packages

Other clinics sell tiers. We don’t. Your protocol is built around your labs and goals, and adjusted at the 6–8-week relab — not pre-loaded onto a credit card before your provider has read your numbers.

Real Compounding Sources

Every peptide is sourced from FDA-registered 503A or 503B compounding pharmacies, with certificates of analysis available on request. No “research chemical” suppliers, no overseas grey-market vials.

Reachable Between Visits

Your medical team is accessible between appointments for questions, side-effect concerns, dosing recalibrations, or sequencing changes around a planned procedure. You won’t be on hold.

Boutique by Design

Luxbae is intentionally small — a single West Hollywood medical spa on Melrose, plus our Glendale location. Your protocol is built and run by the same team, not handed off through five layers of staff.

Your Peptide Journey

Four steps, no preset packages

Every patient runs through the same clinical workflow. The only thing that varies is the protocol that comes out of it.

01

Free Consultation

A complimentary, no-obligation sit-down with our medical team to walk through your goals, current treatments, medications, and full history.

02

Targeted Labs

Where indicated, baseline labs covering hormones, metabolic, inflammatory, and (for GH-axis patients) IGF-1 and full thyroid. Your protocol is anchored to your numbers.

03

Custom Protocol

Dose, cadence, and delivery method are tailored to you. Many protocols are designed around your in-spa treatment cadence (Morpheus8, CO2, PRP) for compounded effect.

04

6–8 Week Refinement

Follow-up labs, dose recalibration, and ongoing direct access to your medical team. Continuity, not a one-time transaction.

Ready when you are

Build your protocol with the Luxbae medical team

Your consultation is complimentary. We’ll walk you through which peptides are clinically relevant to your case, what labs we would draw first, and exactly how your protocol would sequence with your aesthetic plan.

Medical disclaimer: The information on this page is educational and does not constitute medical advice. Many peptides referenced here are not FDA-approved and are currently considered investigational; all such treatments at Luxbae are administered under direct medical supervision by Dr. Ernst von Schwarz and his clinical team. Always consult with a qualified healthcare provider before starting any peptide protocol. Individual results vary.
Scroll to Top